Trending News
News
News
Call for Research
The Food Standards Agency is commissioning a number of surveys of microbiological and chemical contaminants in food, as well as a trial of visual post-mortem inspections in pigs, and a study to investigate the effect of processing on pesticide residues in food.
News
Determination of Cyanuric Acid in Milk Powder by Anion-Exchange Chromatography
This article details how researchers have developed an anion-exchange chromatographic method for simultaneous analysis of cyanuric acid and five inorganic anions in milk powder.
News
Oncolytics Biotech® Inc. Announces First Quarter 2011 Results
Oncolytics has announced financial results and operational highlights for the quarter ended March 31, 2011.
News
Structure-Activity Relationship of New Anti-Tuberculosis Agents Derived from Oxazoline and Oxazole Benzyl Esters
Researchers from the University of Notre Dame have prepared a number of compounds that were shown to possess impressive activity against Mycobacterium tuberculosis, extremely low toxicity and therefore high therapeutic indexes.
News
UT Southwestern Researchers Find Protein that Might be Key to Cutting Cancer Cells’ Blood Supply
Researchers have discovered a protein that guides blood vessel development and eventually might lead to a treatment to keep cancer cells from spreading.
News
Structure Based Drug Designing of a Novel Antiflaviviral Inhibitor for Nonstructural 3 Protein
Researchers have employed molecular docking methodology to explore the NS3 protein's catalytic triad to find out the critical interactions pattern for inhibitor binding.
News
RXi Pharmaceuticals Completes Apthera Acquisition
The acquisition provides RXi with a late stage product candidate, NeuVax™, a peptide-based immunotherapy for low-to-intermediate HER2+ breast cancer, patients who are not eligible for Herceptin® RXi has targeted NeuVax to enter Phase III clinical trials in the first half of 2012.
News
Kantar Health France Names Catherine Verneuil Deputy Head of Oncology Department
Ms. Verneuil will implement the new Oncology Department organizational structure and focus on team management and project profitability.
News
Astellas Pharma and BioFocus Sign Target Discovery Agreement
Collaboration agreement with Astellas focused on discovering novel targets in the field of CNS disorders.
News
Prexa Pharmaceuticals Obtains $7.0 Million in Series B Financing
Funds to bring lead CNS product candidate through Phase 1b studies.
Advertisement